A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans
- PMID: 11549680
- DOI: 10.1210/jcem.86.9.7877
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans
Abstract
Seven studies have now been published pertaining to the acute effect of iv administration of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake. In four of these studies energy intake was significantly reduced following the glucagon-like peptide-1 infusion compared with saline. In the remaining studies, no significant effect of glucagon-like peptide-1 could be shown. Lack of statistical power or low glucagon-like peptide-1 infusion rate may explain these conflicting results. Our aim was to examine the effect of glucagon-like peptide-1 on subsequent energy intake using a data set composed of subject data from previous studies and from two as yet unpublished studies. Secondly, we investigated whether the effect on energy intake is dose dependent and differs between lean and overweight subjects. Raw subject data on body mass index and ad libitum energy intake were collected into a common data set (n = 115), together with study characteristics such as infusion rate, duration of infusion, etc. From four studies with comparable protocol the following subject data were included if available: plasma concentrations of glucagon-like peptide-1, subjective appetite measures, well-being, and gastric emptying rate of a meal served at the start of the glucagon-like peptide-1 infusion. Energy intake was reduced by 727 kJ (95% confidence interval, 548-908 kJ) or 11.7% during glucagon-like peptide-1 infusion. Although the absolute reduction in energy intake was higher in lean (863 kJ) (634-1091 kJ) compared with overweight subjects (487 kJ) (209-764 kJ) (P = 0.05), the relative reduction did not differ between the two groups (13.2% and 9.3%, respectively). Stepwise regression analysis showed that the glucagon-like peptide-1 infusion rate was the only independent predictor of the reduction in energy intake during glucagon-like peptide-1 (7-36) amide infusion (r = 0.4, P < 0.001). Differences in mean plasma glucagon-like peptide-1 concentration on the glucagon-like peptide-1 and placebo day (n = 43) were related to differences in feelings of prospective consumption (r = 0.40, P < 0.01), fullness (r = 0.38, P < 0.05), and hunger (r = 0.26, P = 0.09), but not to differences in ad libitum energy intake. Gastric emptying rate was significantly lower during glucagon-like peptide-1 infusion compared with saline. Finally, well-being was not influenced by the glucagon-like peptide-1 infusion. Glucagon-like peptide-1 infusion reduces energy intake dose dependently in both lean and overweight subjects. A reduced gastric emptying rate may contribute to the increased satiety induced by glucagon-like peptide-1.
Similar articles
-
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.Int J Obes Relat Metab Disord. 2001 Jun;25(6):781-92. doi: 10.1038/sj.ijo.0801627. Int J Obes Relat Metab Disord. 2001. PMID: 11439290 Clinical Trial.
-
No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man.Br J Nutr. 1999 Apr;81(4):273-9. Br J Nutr. 1999. PMID: 10999014 Clinical Trial.
-
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.Int J Obes Relat Metab Disord. 1999 Mar;23(3):304-11. doi: 10.1038/sj.ijo.0800818. Int J Obes Relat Metab Disord. 1999. PMID: 10193877 Clinical Trial.
-
How Satiating Are the 'Satiety' Peptides: A Problem of Pharmacology versus Physiology in the Development of Novel Foods for Regulation of Food Intake.Nutrients. 2019 Jul 4;11(7):1517. doi: 10.3390/nu11071517. Nutrients. 2019. PMID: 31277416 Free PMC article. Review.
-
Effects of polydextrose on different levels of energy intake. A systematic review and meta-analysis.Appetite. 2015 Apr;87:30-7. doi: 10.1016/j.appet.2014.12.099. Epub 2014 Dec 12. Appetite. 2015. PMID: 25510531 Review.
Cited by
-
Stronger control of eating 3 months after sleeve gastrectomy predicts successful weight loss outcomes at one year.Obes Pillars. 2024 May 6;11:100111. doi: 10.1016/j.obpill.2024.100111. eCollection 2024 Sep. Obes Pillars. 2024. PMID: 38770521 Free PMC article.
-
Association of quality and quantity of macronutrients intake with obesity, new anthropometric indices, lipid accumulation, and blood lipid risk index in Tehranian women.Food Sci Nutr. 2024 Feb 4;12(5):3237-3250. doi: 10.1002/fsn3.3991. eCollection 2024 May. Food Sci Nutr. 2024. PMID: 38726395 Free PMC article.
-
The Influence of Acute and Chronic Exercise on Appetite and Appetite Regulation in Patients with Prediabetes or Type 2 Diabetes Mellitus-A Systematic Review.Nutrients. 2024 Apr 11;16(8):1126. doi: 10.3390/nu16081126. Nutrients. 2024. PMID: 38674817 Free PMC article. Review.
-
Targeting the incretin system in obesity and type 2 diabetes mellitus.Nat Rev Endocrinol. 2024 Aug;20(8):447-459. doi: 10.1038/s41574-024-00979-9. Epub 2024 Apr 17. Nat Rev Endocrinol. 2024. PMID: 38632474 Review.
-
Effects of physical form of β-lactoglobulin and calcium ingestion on GLP-1 secretion, gastric emptying and energy intake in humans: a randomised crossover trial.Br J Nutr. 2024 May 28;131(10):1730-1739. doi: 10.1017/S0007114524000321. Epub 2024 Jan 30. Br J Nutr. 2024. PMID: 38287700 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources